The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: Severe acute respiratory infection (SARI) caused by the SARS-CoV-2 virus may cause lung failure and the need for mechanical ventilation. Infection with SARS-COV-2 can lead to activation of inflammatory factors, increased reactive oxygen species, and cell damage. In addition to mucolytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimi, Arash, Samimagham, Hamid Reza, Azad, Mehdi Hassani, Hooshyar, Dariush, Arabi, Mohsen, KazemiJahromi, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040363/
https://www.ncbi.nlm.nih.gov/pubmed/33845881
http://dx.doi.org/10.1186/s13063-021-05242-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040363/
https://www.ncbi.nlm.nih.gov/pubmed/33845881
http://dx.doi.org/10.1186/s13063-021-05242-4

Ejemplares similares